Mithra Pharmaceuticals SA (OTCPK:MITPF)
$ 6.75 0 (0%) Market Cap: 15.66 Mil Enterprise Value: 215.15 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 39/100

Full Year 2021 Mithra Pharmaceuticals SA Earnings Call Transcript

Mar 08, 2022 / 08:00AM GMT
Release Date Price: $22.7
Operator

Hello, and welcome to the Mithra Full Year Results 2021 Conference Call. My name is Jeff, and I'll be your coordinator for today's event. (Operator Instructions)

I will now hand over to your host, Mr. Benoit Mathieu, Head of Investor Relations, to begin today's call. Thank you.

Benoit Mathieu
Mithra Pharmaceuticals SA - Group IR Manager

Good morning, ladies and gentlemen. Welcome to Mithra's Full Year Results 2021. My name is Benoit Mathieu, Group Investor Relations Manager. Thank you all for dialing into this conference call and for being with us for the presentation. I am joined in the room by our CEO, Mr. Leon Van Rompay; Mr. Christophe Marechal, CFO; Mr. Graham Dixon, Chief Scientific Officer; and Mr. Jean-Manuel Fontaine, Chief Business Officer.

This webcast is recorded, and the replay will be accessible later today on Mithra's website.

I would like to remind you that this webcast is covered by the disclaimer on Slide 2 of the presentation. The format of today's call will be as follows. A brief introduction will be given by

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot